BI-1808

Product Description: BI-1808 is a human IgG1 monoclonal antibody that targets TNFR2by blocking interaction of TNFR2 with ligand TNF-α, confers FcγR-dependent depletion of Treg and mediates expansion of intratumoral CD8+ T cells[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Kristoffer Staahl Rohrberg1, et al. 757 Phase 1/2a clinical trial of BI-1808, a monoclonal antibody to tumor necrosis factor receptor 2 (TNFR2) as single agent and in combination with pembrolizumab. J Immunother Cancer 2023;11(Suppl 1):A1–A1731

Molecular Weight: N/A

Compound Purity: 97.75

Research Area: Cancer

Target: TNF Receptor

• SKU: MEXHY-P991192-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P991192-1
• Package Unit: 1 mg
• Quantity Unit: STK
• Conjugate: Unconjugated